MAPT and Alzheimer disease: The result is consistent with the previous work[6a] that hep‐Tau–biotin PFF exhibited significantly less binding to Lag3‐transfected SH‐SY5Y cells (Figure S5a,b, Supporting Information), compared to AD‐Tau–induced Tau PFF‐biotin.